Van Daele, M. (2024). The safety pharmacology of Syk inhibitors: New preclinical screens to characterise cardiovascular adverse drug effects.
Chicago Style (17th ed.) CitationVan Daele, Marieke. The Safety Pharmacology of Syk Inhibitors: New Preclinical Screens to Characterise Cardiovascular Adverse Drug Effects. 2024.
MLA (9th ed.) CitationVan Daele, Marieke. The Safety Pharmacology of Syk Inhibitors: New Preclinical Screens to Characterise Cardiovascular Adverse Drug Effects. 2024.
Warning: These citations may not always be 100% accurate.